Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.
Matsukawa A, Yanagisawa T, Bekku K, Kardoust Parizi M, Laukhtina E, Klemm J, Chiujdea S, Mori K, Kimura S, Fazekas T, Miszczyk M, Miki J, Kimura T, Karakiewicz PI, Rajwa P, Shariat SF. Matsukawa A, et al. Among authors: miszczyk m. Eur Urol Oncol. 2024 Jan 4:S2588-9311(23)00292-4. doi: 10.1016/j.euo.2023.12.005. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38182488 Free article. Review.
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer.
Miszczyk M, Rembak-Szynkiewicz J, Magrowski Ł, Stawiski K, Namysł-Kaletka A, Napieralska A, Kraszkiewicz M, Woźniak G, Stąpór-Fudzińska M, Głowacki G, Pradere B, Laukhtina E, Rajwa P, Majewski W. Miszczyk M, et al. Cancers (Basel). 2022 Mar 23;14(7):1613. doi: 10.3390/cancers14071613. Cancers (Basel). 2022. PMID: 35406385 Free PMC article.
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk.
Miszczyk M, Szołtysik M, Hasterok M, Goldner G, Rajwa P, Namysł-Kaletka A, Napieralska A, Kraszkiewicz M, Stąpór-Fudzińska M, Tomasik B, Woźniak G, Głowacki G, Kaminiów K, Moll M, Magrowski Ł, Majewski W. Miszczyk M, et al. Biomedicines. 2022 Sep 30;10(10):2446. doi: 10.3390/biomedicines10102446. Biomedicines. 2022. PMID: 36289708 Free PMC article.
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy.
Magrowski Ł, Masri O, Ciepał J, Depowska G, Nowicka Z, Stando R, Chimiak K, Bylica G, Czapla B, Masri M, Cichur F, Jabłońska I, Gmerek M, Wojcieszek P, Krzysztofiak T, Sadowski J, Suwiński R, Rajwa P, Moll M, Goldner G, Majewski W, Miszczyk M. Magrowski Ł, et al. Among authors: miszczyk m. Biomedicines. 2022 Oct 8;10(10):2514. doi: 10.3390/biomedicines10102514. Biomedicines. 2022. PMID: 36289778 Free PMC article.
Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity.
Miszczyk M, Kraszkiewicz M, Moll M, Kaminiów K, Sobel S, Dolla Ł, Wojcieszek P, Rajwa P, Yanagisawa T, Nowicka Z, Shariat SF, Goldner G, Miszczyk L, Majewski W. Miszczyk M, et al. Among authors: miszczyk l. Cancers (Basel). 2023 Feb 13;15(4):1180. doi: 10.3390/cancers15041180. Cancers (Basel). 2023. PMID: 36831523 Free PMC article.
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients.
Miszczyk M, Magrowski Ł, Krzysztofiak T, Stando R, Majewski W, Stawiski K, Masri O, Ciepał J, Depowska G, Chimiak K, Bylica G, Czapla B, Masri M, Cichur F, Jabłońska I, Gmerek M, Nowicka Z, Wojcieszek P, Sadowski J, Suwiński R, Rajwa P, Goldner G, Moll M. Miszczyk M, et al. Radiother Oncol. 2023 Jun;183:109632. doi: 10.1016/j.radonc.2023.109632. Epub 2023 Mar 23. Radiother Oncol. 2023. PMID: 36963442 Free article.
Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.
Ślusarczyk A, Baboudjian M, Zapała P, Yanagisawa T, Miszczyk M, Chlosta M, Krumpoeck P, Moschini M, Gandaglia G, Ploussard G, Rivas JG, Życzkowski M, Karakiewicz PI, Radziszewski P, Leapman MS, Shariat SF, Rajwa P. Ślusarczyk A, et al. Among authors: miszczyk m. Prostate. 2023 Nov;83(15):1504-1515. doi: 10.1002/pros.24609. Epub 2023 Aug 7. Prostate. 2023. PMID: 37545342
49 results